Celltrion gets interchangeability approval for biosimilar of Humira in US
Celltrion targets $3.46 bn in sales this year on biosimilars
Celltrion launches autoimmune disease treatment in US
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar
Celltrion's autoimmune disease treatment gets approval in Europe
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment
Celltrion's autoimmune disease treatment hits 5 major European countries
S. Korea fines pharma giant Celltrion for unfair business practices
S. Korean drugmaker Celltrion to buy back its shares for 4th time in 2024
